Reliv' International (Reliv' International) Total Liabilities : $5.27 Mil (As of Sep. 2020)

View and export this data going back to 1993. Start your Free Trial

What is Reliv' International Total Liabilities?

Reliv' International's Total Liabilities for the quarter that ended in Sep. 2020 was $5.27 Mil.

Reliv' International's quarterly Total Liabilities increased from Mar. 2020 ($5.32 Mil) to Jun. 2020 ($5.35 Mil) but then declined from Jun. 2020 ($5.35 Mil) to Sep. 2020 ($5.27 Mil).

Reliv' International's annual Total Liabilities declined from Dec. 2017 ($6.71 Mil) to Dec. 2018 ($4.36 Mil) and declined from Dec. 2018 ($4.36 Mil) to Dec. 2019 ($4.21 Mil).

Reliv' International Total Liabilities Historical Data

The historical data trend for Reliv' International's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Reliv' International Total Liabilities Chart

Reliv' International Annual Data

Trend

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Total Liabilities

Get a 7-Day Free Trial

8.38

7.55

6.71

4.36

4.21

Reliv' International Quarterly Data
	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20
Total Liabilities	Get a 7-Day Free Trial															5.29	4.21	5.32	5.35	5.27

Reliv' International Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Reliv' International's Total Liabilities for the fiscal year that ended in Dec. 2019 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	3.989	+	(0.104	+	0.112
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	4.21

Total Liabilities	=	Total Assets (A: Dec. 2019 )	-	Total Equity (A: Dec. 2019 )
	=	15.307	-	11.102
	=	4.21

Reliv' International's Total Liabilities for the quarter that ended in Sep. 2020 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	4.674	+	(0.473	+	0.126
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	5.27

Total Liabilities	=	Total Assets (Q: Sep. 2020 )	-	Total Equity (Q: Sep. 2020 )
	=	16.707	-	11.434
	=	5.27

Reliv' International Total Liabilities Related Terms

Thank you for viewing the detailed overview of Reliv' International's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Reliv' International (Reliv' International) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Reliv' International Inc (OTCPK:RELV) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

136 Chesterfield Industrial Boulevard, Chesterfield, MO, USA, 63005

Website

https://www.reliv.com

Reliv' International Inc is a developer, manufacturer, and marketer of a proprietary line of nutritional supplements addressing basic nutrition, specific wellness needs, weight management, and sports nutrition. The company sells its products throughout the United States and in Australia, Austria, Canada, France, Germany, Ireland, Malaysia, Mexico, the Netherlands, New Zealand, the Philippines, United Kingdom and Asia, through an international network marketing system using independent distributors. It generates a majority of its revenue from the United States.

Executives

Stephen M Merrick	other: No longer director	401 S LASALLE STREET SUITE 1302, CHICAGO IL 60605
Robert L Montgomery	director, 10 percent owner, officer: Chief Executive Officer	136 CHESTERFIELD INDUSTRIAL BLVD CHESTERFIELD MO 63005
Carl W Hastings	director, officer: Chief Scientific Officer	136 CHESTERFIELD INDUSTRIAL BLVD CHESTERFIELD MO 63005
Scott Montgomery	officer: Vice President	136 CHESTERFIELD INDUSTRIAL BOULEVARD CHESTERFIELD MO 63005
Ryan Andrew Montgomery	officer: Vice President	136 CHESTERFIELD INDUSTRIAL BOULEVARD CHESTERFIELD MO 63005
Steven Albright	officer: Chief Financial Officer
Gibbons Donald E Jr	officer: Vice President U.S. Sales	136 CHESTERFIELD INDUSTRIAL BLVD CHESTERFIELD IL 63005
Steven G Hastings	officer: Vice President	136 CHESTEFIELD INDUSTRIAL BOULEVARD CHESTERFIELD MO 63005
Brett M Hastings	officer: Associate General Counsel	136 CHESTERFIELD INDUSTRIAL BLVD CHESTERFIELD MO 63005
Kurt C Wulff	officer: Associate General Counsel	136 CHESTERFIELD INDUSTRIAL BLVD CHESTERFIELD MO 63005
Debra P Hellweg	officer: Vice President Operations	136 CHESTERFIELD INDUSTRIAL BOULEVARD CHESTERFIELD MO 63005
John Denis St	director	12801 FLUSHING MEADOWS DR SUITE 100 ST LOUIS MO 63131
Ronald W Mccain	officer: Dir of Distributor Services	136 CHESTERFIELD INDUSTRIAL BOULEVARD CHESTERFIELD MO 63005
Wojcik Joseph J Jr	officer: VP of Operations	136 CHESTERFIELD INDUSTRIAL BOULEVARD CHESTERFIELD MO 63005
John M Klimek	director	136 CHESTERFIELD INDUSTRIAL BOULEVARD, CHESTERFIELD MO 63005